Nexgel, Inc. NXGL
Institutional shares held
469,504
0
calls
0
puts
Total value of holdings
$1.68M
$0
calls
$0
puts
Market Cap
$19.9M
5,572,230
Shares Out.
Institutional ownership
8.43%
# of Institutions
17
We take great care to ensure that the data presented and summarized in this overview for NEXGEL, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NXGL
View all-
Jim Simons Renaissance Technologies LLC | New York, Ny158KShares$565,2410.0% of portfolio
-
Morgan Stanley New York, NY87.8KShares$313,4600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA60.1KShares$214,7060.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA50KShares$178,4100.0% of portfolio
-
Simon Quick Advisors, LLC35.7KShares$127,5020.01% of portfolio
-
New Edge Advisors, LLC New Orleans, LA20.3KShares$72,4530.0% of portfolio
-
State Street Corp Boston, MA17.3KShares$61,6140.0% of portfolio
-
Two Sigma Securities, LLC New York, NY12KShares$42,9640.01% of portfolio
-
Ifp Advisors, Inc11KShares$39,2700.0% of portfolio
-
Virtu Financial LLC New York, NY10.8KShares$38,5060.0% of portfolio
Latest Institutional Activity in NXGL
Top Purchases
Top Sells
About NXGL
NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was founded in 1997 and is based in Langhorne, Pennsylvania.
Insider Transactions at NXGL
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 12
2025
|
Scott Robert Henry Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.74%
|
-
|
|
Feb 12
2025
|
Steven Mark Glassman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,500
+1.57%
|
-
|
|
Feb 10
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.12%
|
$9,000
$3.27 P/Share
|
|
Feb 03
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.05%
|
$12,000
$3.64 P/Share
|
|
Jan 07
2025
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.08%
|
$9,000
$3.37 P/Share
|
|
Jan 02
2025
|
Adam R. Levy Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,000
-1.04%
|
$12,000
$3.96 P/Share
|
|
Jan 02
2025
|
Adam R. Levy Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
26,116
+6.33%
|
-
|
|
Dec 20
2024
|
Scott Robert Henry Director |
SELL
Open market or private sale
|
Direct |
3,000
-2.03%
|
$12,000
$4.64 P/Share
|
|
Nov 20
2024
|
Nachum Stein Director |
BUY
Open market or private purchase
|
Direct |
3,636
+0.77%
|
$7,272
$2.75 P/Share
|
|
Nov 20
2024
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
9,090
+5.57%
|
$18,180
$2.75 P/Share
|
|
Nov 20
2024
|
Adam E Drapczuk Iii Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
17,500
+18.94%
|
$35,000
$2.75 P/Share
|
|
Nov 20
2024
|
Jerome B Zeldis Director |
BUY
Open market or private purchase
|
Direct |
3,636
+3.3%
|
$7,272
$2.75 P/Share
|
|
Nov 20
2024
|
Adam R. Levy Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
3,636
+1.08%
|
$7,272
$2.75 P/Share
|
|
Nov 20
2024
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
1,818
+1.22%
|
$3,636
$2.75 P/Share
|
|
Nov 07
2024
|
Nachum Stein Director |
SELL
Bona fide gift
|
Direct |
4,000
-0.85%
|
-
|
|
Aug 23
2024
|
Nachum Stein Director |
BUY
Open market or private purchase
|
Direct |
10,000
+2.08%
|
$20,000
$2.5 P/Share
|
|
Aug 23
2024
|
Steven Mark Glassman Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.45%
|
$20,000
$2.5 P/Share
|
|
Aug 23
2024
|
Adam E Drapczuk Iii Chief Financial Officer |
BUY
Open market or private purchase
|
Indirect |
10,000
+14.84%
|
$20,000
$2.5 P/Share
|
|
Aug 23
2024
|
Scott Robert Henry Director |
BUY
Open market or private purchase
|
Direct |
10,000
+6.42%
|
$20,000
$2.5 P/Share
|
|
Aug 23
2024
|
Jerome B Zeldis Director |
BUY
Open market or private purchase
|
Direct |
10,000
+8.85%
|
$20,000
$2.5 P/Share
|
Last 12 Months Summary
Buy / Acquisition
203K
Shares
From
9
Insiders
| Open market or private purchase | 172K shares |
|---|---|
| Grant, award, or other acquisition | 31.1K shares |
Sell / Disposition
21K
Shares
From
3
Insiders
| Open market or private sale | 17K shares |
|---|---|
| Bona fide gift | 4K shares |